Variables | Category | N (%) |
---|---|---|
Age | ≤ 1 years | 7 (5.2) |
> 1 year to ≤ 5 years | 73 (54.1) | |
> 5 years to ≤ 10 years | 41 (30.4) | |
> 10 years to ≤ 15 years | 12 (8.9) | |
Sex | Male | 93 (68.9) |
Female | 42 (31.1) | |
Type of malignancy | Acute lymphocytic leukemia | 71 (52.6) |
Acute myeloid leukemia | 10 (7.4) | |
Non-Hodgkin lymphoma | 10 (7.4) | |
Blastomas | 17 (12.6) | |
Sarcomas | 15 (11.1) | |
Othersa | 12 (8.9) | |
Presence of co morbid illness | Hypertension | 10 (7.4) |
Congestive heart failure | 6 (4.4) | |
Tuberculosis | 1 (0.7) | |
Othersb | 9 (6.7) | |
ANC value before starting treatment (cell/mm3) | < 500 | 120 (88.9) |
500–1000 | 9 (6.7) | |
1000–1500 | 5 (3.7) | |
> 1500 | 1 (0.7) | |
Focus of neutropenic infection | Chest focus | 15 (11.1) |
Gastro intestinal focus | 5 (3.7) | |
Urinary focus | 2 (1.5) | |
Unknown focus | 113 (83.7) | |
Patients fulfillment FN diagnostic criteria | Yes | 116 (85.9) |
No | 19 (14.1) | |
FN diagnosed | Before initiation of chemotherapy | 47 (34.8) |
After chemotherapy | 88 (65.2) |